Search

Antitubulinic effect of New Fluorazone Derivatives on Melanoma Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16 Issue: 5 Year: 2016 Page: 601-608
Author(s): Claudia Sticozzi,Francesca Aiello,Rita Bassi Andreasi,Ximena Maria Muresan,Giuseppe Belmonte,Franco Cervellati,Emilia Maellaro,Emanuela Maioli,Giuseppe Valacchi

Thiazolidinone Constraint Combretastatin Analogs as Novel Antitubulin Agents: Design, Synthesis, Biological Evaluation and Docking Studies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 2 Year: 2017 Page: 230-240
Author(s): Sahil Sharma,Manish Kumar Gupta,Ajit Kumar Saxena,Preet Mohinder Singh Bedi

Design of Combretastatin A-4 Analogs as Tubulin Targeted Vascular Disrupting Agent with Special Emphasis on Their Cis-Restricted Isomers

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 10 Year: 2013 Page: 1923-1955
Author(s): Harish Rajak,Pramod Kumar Dewangan,Vijay Patel,Deepak Kumar Jain,Avineesh Singh,Ravichandran Veerasamy,Prabodh Chander Sharma,Anshuman Dixit

Journal: Medicinal Chemistry
Volume: 9 Issue: 4 Year: 2013 Page: 510-516
Author(s): Maleeruk Utsintong, Alberto Massarotti, Antonio Caldarelli, Sewan Theeramunkong

Synthesis and Biological Evaluation of 2-aroyl-4-phenyl-5- hydroxybenzofurans as a New Class of Antitubulin Agents

Journal: Medicinal Chemistry
Volume: 4 Issue: 6 Year: 2008 Page: 558-564
Author(s): Romeo Romagnoli, Pier Giovanni Baraldi, Taradas Sarkar, Carlota Lopez Cara, Olga Cruz Lopez, Maria Dora Carrion, Delia Preti, Manlio Tolomeo, Jan Balzarini, Ernest Hamel

Synthesis and Biological Evaluation of 2-amino-3-(3, 4, 5-trimethoxyphenylsulfonyl)-5-aryl thiophenes as a New Class of Antitubulin Agents

Journal: Medicinal Chemistry
Volume: 3 Issue: 6 Year: 2007 Page: 507-512
Author(s): Romeo Romagnoli, Pier Giovanni Baraldi, Vincent Remusat, Maria Dora Carrion, Carlota Lopez Cara, Olga Cruz-Lopez, Delia Preti, Francesca Fruttarolo, Mojgan Aghazadeh Tabrizi, Jan Balzarini, Ernest Hamel

Tubulin Folding Pathways: Implication in the Regulation of Microtubule Dynamics

Journal: Current Cancer Drug Targets
Volume: 7 Issue: 8 Year: 2007 Page: 697-703
Author(s): A. Beghin, C. M. Galmarini, C. Dumontet

Synthesis and Pharmacological Effects of the Anti-Cancer Agent 2-Methoxyestradiol

Journal: Current Pharmaceutical Design
Volume: 21 Issue: 3 Year: 2015 Page: 5453-5466
Author(s): Eirik Johansson Solum, Oyvind W. Akselsen, Anders Vik, Trond Vidar Hansen

Drugs that Inhibit Tubulin Polymerization: The Particular Case of Podophyllotoxin and Analogues

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 2 Issue: 1 Year: 2002 Page: 71-90
Author(s): Stephanie Desbene, Sylviane Giorgi-Renault

Delineation of Current Development of Antimitotic Compounds Targeting Cytoskeletal Protein Tubulin and Microtubule in the Cancer Therapy

Journal: Current Chemical Biology
Volume: 8 Issue: 3 Year: 2014 Page: 165-183
Author(s): Suvroma Gupta